PodChatLive - The Podiatry Podcast

In this episode we welcomed Steve Jamieson (CEO of the College of Podiatry, UK) and Nello Marino (CEO of the Australian Podiatry Association) to discuss the strange and unprecedented situation we have all found ourself in in recent times due to the current global pandemic. We discussed what their daily lives currently look like, how they are trying to support their members, their understanding of what their members greatest concerns are and also the support they are giving all members through this time. It is clear that individuals are responding differently due to variance in their working situations and also their own mindset and approach to such a situation; so when you combine this with an evolving understanding of what we are actually dealing with on a global scale it is unsurprising that there are no black and white answers.

In this episode we welcomed Steve Jamieson (CEO of the College of Podiatry, UK) and Nello Marino (CEO of the Australian Podiatry Association) to discuss the strange and unprecedented situation we have all found ourself in in recent times due to the current global pandemic. We discussed what their daily lives currently look like, how they are trying to support their members, their understanding of what their members greatest concerns are and also the support they are giving all members through this time. It is clear that individuals are responding differently due to variance in their working situations and also their own mindset and approach to such a situation; so when you combine this with an evolving understanding of what we are actually dealing with on a global scale it is unsurprising that there are no black and white answers.

In this episode we talked to Dr Sharon Rees who is an Associate Professor in Therapeutics & Prescribing at London South Bank University, and began her career as a Podiatrist. She clarifies the difference between administering, supplying and prescribing drugs, talks through the list of drugs accessible via the POM certificate most graduate Podiatrists hold and what a commitment but worthwhile consideration doing an independent prescribing course would be. She also explained why certain drugs must be taken before or with food, busted the myth about drinking alcohol and taking antibiotics and reminded us of some of the common (arthralgia, myalgia) and less common (tendon pathology) side effects of certain drug groups.

In this episode we were joined by Mike James to talk about online consultations. This was a really useful episode for those who have recently starting doing (or are considering doing) online consultations. We covered some of the legal aspects, the options available technology wise, things to put in place preparation wise beforehand, and then what a consultation may look like (both subjectively and objectively). Without doubt a fundamental shift in mindset/approach is required from all parties, but a global pandemic is a pretty reasonable motivator for change.

In this episode we talked with Talysha Reeve about the considerations Podiatrists should have when providing rehabilitation clinically, how important clinical reasoning is, and whether "just getting strong" was good enough. We also covered the pragmatic approach to rehab in the real world; talking through biopsychosocial considerations, patient adherence, behaviour change and how well rehabilitation lends itself to online/remote consultations.

Live podiatry chats with Craig Payne and Ian Griffiths. In this episode were joined by Kevin Kirby, Sean MeBride and Simon Spooner to discuss the lifetime of the supination resistance test, from the genesis of the manual supination resistance test (and how to perform it), through the all published research on the test and the various supination devices that have been designed to quantify it. We also talk about the imperfections and limitations of the supination resistance test, and what research is still needed regarding it.

In this episode we talk with Michael Nitschke ("Nitta") about the holy grail - running shoes that *might* reduce injury rates. In the week that Nike release the Infinity React we discuss the marketing behind the shoe, the study behind the marketing and take a deeper dive into the world of running shoes and their relationship/influence on injuries. How should (can?) we prescribe shoes to reduce injury? Is it all just about comfort? Will we ever actually know what we are doing...?

In this episode we do some revision of the structural anatomy of the Tibialis Posterior muscle and tendon unit, and discuss what Jayishni Maharaj studied for her PhD with regard to its function, role in energy absorption and influence on STJ energetics. We discuss the correlation with foot posture and foot mobility, and also some of the management strategies we often use (footwear advice, foot orthoses and strengthening/exercise) along with one which many may not be aware of (increasing step width).

In this episode with are joined by Matt Cotchett who has published extensively within the field of plantar heel pain, and in this episode we tackle the topic of terminology (fasciitis Vs fasciopathy Vs PHP), the associated psychological variables, dry needling, and the best evidence based practice/approach to treating heel pain in clinic. More: plantar fasciitis treatment

In this episode we had great fun with Alex Hutchinson talking about the running shoe/s which appears to have moved the needle more than any other shoe in history; the Nike Vaporfly/Next%/Alphafly. Do they come good on their marketing promise of improving runners by 4% (and what does that actually mean)? Where does the line between innovation and 'shoe doping' get drawn? Are they only for elite runners? All this and more.